In vitro Antifungal Susceptibility Testing of Clinical and Environmental Fusarium Isolates in Iran

[1]  J. Meis,et al.  Fusarium species causing eumycetoma: Report of two cases and comprehensive review of the literature , 2017, Mycoses.

[2]  G. S. de Hoog,et al.  Phylogenetic analysis of dermatophyte species using DNA sequence polymorphism in calmodulin gene. , 2016, Medical mycology.

[3]  J. Meis,et al.  In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis. , 2016, The Journal of antimicrobial chemotherapy.

[4]  J. Meis,et al.  Fusarium: Molecular Diversity and Intrinsic Drug Resistance , 2016, PLoS pathogens.

[5]  M. Shams-Ghahfarokhi,et al.  Giberella fujikuroi species complex isolated from maize and wheat in Iran: distribution, molecular identification and fumonisin B1 in vitro biosynthesis. , 2016, Journal of the science of food and agriculture.

[6]  J. Meis,et al.  Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Genus Fusarium Causing Human Keratomycosis in South India. , 2016, Medical mycology.

[7]  F. Zaini,et al.  The antagonistic effects of Candida parapsilosis on the growth of Fusarium species and fumonisin production , 2016, Current medical mycology.

[8]  J. Meis,et al.  Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 , 2016, Emerging microbes & infections.

[9]  T. Boekhout,et al.  Phylogenetic diversity of human pathogenic Fusarium and emergence of uncommon virulent species. , 2015, The Journal of infection.

[10]  B. Sampaio-Maia,et al.  Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  J. Meis,et al.  Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. , 2014, The Journal of antimicrobial chemotherapy.

[12]  A. Quesada,et al.  Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. , 2015, The Journal of antimicrobial chemotherapy.

[13]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  Koichiro Tamura,et al.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. , 2013, Molecular biology and evolution.

[15]  Springer-Verlag,et al.  Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  S. Balajee,et al.  Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital , 2013, BMC Infectious Diseases.

[17]  M. Suh,et al.  Onychomycosis Due to Nondermatophytic Molds , 2012, Annals of dermatology.

[18]  B. Piraccini,et al.  Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. , 2012, Journal of the American Academy of Dermatology.

[19]  F. Grenouillet,et al.  International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole , 2010, Antimicrobial Agents and Chemotherapy.

[20]  M. Chadeganipour,et al.  Study of onychomycosis in Isfahan, Iran , 2010, Mycoses.

[21]  S. A. Ghiasian,et al.  Onychomycosis in Iran: epidemiology, causative agents and clinical features. , 2010, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[22]  S. Restrepo,et al.  Fusarium species detected in onychomycosis in Colombia , 2009, Mycoses.

[23]  J. Guarro,et al.  Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here? , 2008, Journal of Clinical Microbiology.

[24]  Kerry O'Donnell,et al.  Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within the Fusarium solani Species Complex , 2008, Journal of Clinical Microbiology.

[25]  J. Guarro,et al.  In Vitro Antifungal Susceptibility and Molecular Characterization of Clinical Isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum , 2008, Antimicrobial Agents and Chemotherapy.

[26]  E. Mellado,et al.  Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. , 2008, The Journal of antimicrobial chemotherapy.

[27]  E. Anaissie,et al.  Fusarium Infections in Immunocompromised Patients , 2007, Clinical Microbiology Reviews.

[28]  J. Guarro,et al.  Universal In Vitro Antifungal Resistance of Genetic Clades of the Fusarium solani Species Complex , 2007, Antimicrobial Agents and Chemotherapy.

[29]  H. Kistler,et al.  Heading for disaster: Fusarium graminearum on cereal crops. , 2004, Molecular plant pathology.

[30]  S. Rezayat,et al.  Mycoflora of Iranian Maize Harvested in the Main Production Areas in 2000 , 2004, Mycopathologia.

[31]  E. Anaissie,et al.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  J. Rex,et al.  In Vitro Activities of Investigational Triazoles against Fusarium Species: Effects of Inoculum Size and Incubation Time on Broth Microdilution Susceptibility Test Results , 2002, Antimicrobial Agents and Chemotherapy.

[33]  B. Nare,et al.  Evaluation of a Cyclic GMP-Dependent Protein Kinase Inhibitor in Treatment of Murine Toxoplasmosis: Gamma Interferon Is Required for Efficacy , 2002, Antimicrobial Agents and Chemotherapy.

[34]  B. Piraccini,et al.  Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. , 2000, Journal of the American Academy of Dermatology.

[35]  E. Anaissie,et al.  Taxonomy, biology, and clinical aspects of Fusarium species , 1994, Clinical Microbiology Reviews.

[36]  G. Wickern.  Fusarium allergic fungal sinusitis. , 1993, The Journal of allergy and clinical immunology.